Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRP | O00591 | 13/20 | 0.64 |
| ▸ | GABRD | O14764 | 13/20 | 0.64 |
| ▸ | GABRA1 | P14867 | 13/20 | 0.64 |
| ▸ | GABRB1 | P18505 | 13/20 | 0.64 |
| ▸ | GABRG2 | P18507 | 13/20 | 0.64 |
| ▸ | GABRB3 | P28472 | 13/20 | 0.64 |
| ▸ | GABRA5 | P31644 | 13/20 | 0.64 |
| ▸ | GABRA3 | P34903 | 13/20 | 0.64 |
| ▸ | GABRA2 | P47869 | 13/20 | 0.64 |
| ▸ | GABRB2 | P47870 | 13/20 | 0.64 |
| ▸ | GABRA4 | P48169 | 13/20 | 0.64 |
| ▸ | GABRE | P78334 | 13/20 | 0.64 |
| ▸ | GABRA6 | Q16445 | 13/20 | 0.64 |
| ▸ | GABRG1 | Q8N1C3 | 13/20 | 0.64 |
| ▸ | GABRG3 | Q99928 | 13/20 | 0.64 |
| ▸ | GABRQ | Q9UN88 | 13/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | PDE5A | O76074 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27905853 | 0.87 | GABRP (0.67) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL9536124 | 0.84 | GABRA1 (0.46) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL25290088 | 0.83 | GABRP (0.67) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL9836444 | 0.81 | GABRA1 (0.66) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL9835964 | 0.81 | GABRA1 (0.67) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL2216289 | 0.79 | GABRP (0.68) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL9839951 | 0.79 | GABRA1 (0.46) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL10646617 | 0.78 | GABRA1 (1.00) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL29381558 | 0.77 | GABRA1 (1.00) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL1180278 | 0.77 | GABRA1 (1.00) | GABRPGABRDGABRA1GABRB1GABRG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0239667-B1 | 5-OR 6-SUBSTITUTED BETA-CARBOLINE-3-CARBOXYLIC-ACID ESTERS | SCHERING AKTIENGESELLSCHAFT (DE) | 1991-05-02 | — | — | EP | claimed |
| EP-0130141-B1 | BETA-CARBOLINES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1990-09-12 | — | — | EP | claimed |
| EP-0239667-A1 | 5-or 6-Substituted beta-carboline-3-carboxylic-acid esters | SCHERING AKTIENGESELLSCHAFT (DE) | 1987-10-07 | — | — | EP | claimed |
| EP-0234173-B1 | PHENOXY-SUBSTITUTED BETA-CARBOLINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1993-06-16 | — | — | EP | disclosed |
| EP-0237467-B1 | HETEROARYL-OXY-BETA-CARBOLINE DERIVATIVES, THEIR PREPARATION AND USE AS MEDICAMENTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1992-10-28 | — | — | EP | disclosed |
| EP-0217737-B1 | TETRAHYDRO-BETA-CARBOLINES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1991-08-14 | — | — | EP | disclosed |
| EP-0239667-B1 | 5-OR 6-SUBSTITUTED BETA-CARBOLINE-3-CARBOXYLIC-ACID ESTERS | SCHERING AKTIENGESELLSCHAFT (DE) | 1991-05-02 | — | — | EP | disclosed |
| EP-0222693-B1 | 3-OXADIAZOLYL AND 3-CARBOXYLIC-ACID BETA-CARBOLINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICAMENTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1991-04-17 | — | — | EP | disclosed |
| EP-0130141-B1 | BETA-CARBOLINES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1990-09-12 | — | — | EP | disclosed |
| EP-0137390-B1 | SUBSTITUTED BETA-CARBOLINES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1990-08-16 | — | — | EP | disclosed |
| EP-0110814-B1 | BETA-CARBOLINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | SCHERING AKTIENGESELLSCHAFT (DE) | 1989-12-13 | — | — | EP | disclosed |
| EP-0239667-A1 | 5-or 6-Substituted beta-carboline-3-carboxylic-acid esters | SCHERING AKTIENGESELLSCHAFT (DE) | 1987-10-07 | — | — | EP | disclosed |
| EP-0239667-A1 | 5-or 6-Substituted beta-carboline-3-carboxylic-acid esters | SCHERING AKTIENGESELLSCHAFT (DE) | 1987-10-07 | — | — | EP | disclosed |
| EP-0237467-A2 | Heteroaryl-oxy-beta-carboline derivatives, their preparation and use as medicaments | SCHERING AKTIENGESELLSCHAFT (DE) | 1987-09-16 | — | — | EP | disclosed |
| US-4596808-A | Nervous system disorders | SCHERING AKTIENGESELLSCHAFT (DE) | 1986-06-24 | — | — | US | disclosed |
| EP-0110814-A2 | Beta-carbolines, process for their preparation and pharmaceutical compositions containing them | SCHERING AKTIENGESELLSCHAFT (DE) | 1984-06-13 | — | — | EP | disclosed |